Viatris Inc (XSWX:VTRS)
CHF 13.06 +0.080 (+0.62%) Market Cap: 15.25 Bil Enterprise Value: 25.13 Bil PE Ratio: 0 PB Ratio: 1.29 GF Score: 60/100

Viatris Inc at Evercore ISI Healthcare Conference Transcript

Dec 03, 2025 / 01:45PM GMT
Umer Raffat
Evercore Inc - Equity Analyst

Okay. Thank you, guys, for being here. Super excited to have Viatris management join us. I think the last time we had you guys, Rajiv used to be irregular, and he would always fly in, and we would just go freestyle on so many different ANDAs with him, but excited to speak to you. And I feel like when Rajiv would come down every time, there were so many ends that were so interesting, but I feel like this time around, I think it's much more the strategy and broader conversation on where the story is heading, both from the base business and financials.

So Scott, I'll let you kick things off perhaps.

Scott Smith
Viatris Inc - Chief Executive Officer, Director

Sure. So when I think about Viatris, I think it's not one business, right? It's for three separate businesses. It's a global generics footprint, which was a Mylan company. These established products, some of the most iconic brands in the world, the Lipitors, Norvasc, Xanax, Viagra, Celebrex, that came through the Upjohn acquisition, and then there's a

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot